About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  

Active Clinical Trials

ADHD in adults - Double-Blind Placebo Control Safety and Feasibility Study

Tel Aviv Medical Center, Israel

1 July, 2011

A clinical trial in attention deficit and hyperactivity disorder (ADHD) patients has begun at the Tel Aviv Medical Center, Israel.


Obsessive Compulsive Disorder - Double-Blind Placebo Control Safety and Feasibility Study

Sheba Medical Center, Tel Hashomer, Israel

1 June, 2011

A clinical trial in obsessive compulsive disorder (OCD) patients has begun at the Sheba Medical Center, Tel Hashomer, Israel.


Cocaine Addiction - Double-Blind Placebo Control Safety and Feasibility Study

Columbia University, New York, NY, USA

2 January, 2011

A clinical trial of Brainsway's Deep TMS device for the treatment of cocaine withdrawal has begun at Columbia University, New York. The trial will be performed by the Research Foundation for Mental Hygiene, Inc., a research center which operates in collaboration with Columbia University. The effects of Deep TMS will be assessed using PET scanning to monitor metabolic processes in the body. The trial will follow a double-blind design with a control group.


Tourette Syndrome - Double-Blind Placebo Control Safety and Feasibility Study

Shalvata Mental Health Center, Hod-Hasharon, Israel

3 October, 2010

A clinical trial of Brainsway's Deep TMS device for the treatment of subjects with Tourette syndrome has begun at the Shalvata Mental Health Center.


Gambling Addiction Double-Blind Placebo Control Safety and Feasibility Study

Be'er Ya'akov Mental Health Center, Israel

1 June, 2010

A double-blind placebo-controlled clinical trial for pathological gambling has begun at the Mental Health Center in Be'er Ya'akov, Israel.


Multiple Sclerosis - Double-Blind Placebo Control Safety and Feasibility Study

Charité University, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany

21 March, 2010

A clinical trial of Brainsway's Deep TMS for the treatment of multiple sclerosis patients (MS) has begun in two leading medical centers in Germany: the Charité Hospital – considered to be the leading university hospital in Berlin, and the University Medical Center Hamburg-Eppendorf, in Hamburg.


Stroke Rehabilitation - Double-Blind Placebo Control Safety and Feasibility Study

Hadassah Medical Organization, Jerusalem, Israel.

1 March, 2009

A clinical trial using Brainsway's Deep TMS device for the rehabilitation of stroke patients has begun.

The trial is designed determine the safety and efficacy of deep transcranial magnetic stimulation (TMS) in treating acute ischemic stroke (stroke resulting from a blood clot in the brain).


Smoking Cessation in Chronic Obstructive Pulmonary Disease - Double-Blind Placebo Control Safety and Feasibility Study

Be'er Ya'akov Mental Health Center, Israel

1 July, 2009

A clinical trial for the assessment of the efficacy of Deep TMS in inducing smoking cessation in chronic obstructive pulmonary disease patients, has begun at the Mental Health Center in Be'er Ya'akov, Israel.


Alzheimer's Disease - Double-Blind Placebo Control Safety and Feasibility Study

Ichilov Medical Center, Tel-Aviv, Israel

7 April, 2009

A clinical trial using Brainsway's Deep TMS device for the treatment of Alzheimer's disease has begun at the Ichilov Medical Center, Tel-Aviv, Israel.

40 patients are expected to take part in the trial.


Schizophrenia Negative Symptoms - Double-Blind Placebo Control Safety and Feasibility Study

Shalvata Mental Health Center, Hod Hasharon, Israel

9 March, 2009

A double-blind placebo-controlled clinical trial utilizing the Brainsway's Deep TMS device for the treatment of negative symptoms in 45 patients with schizophrenia has begun at the Shalvata Mental Health Center.


Bipolar Disorder - Double-Blind Placebo Control Safety and Feasibility Study

Shalvata Mental Health Center, Hod-Hasharon, Israel

13 January, 2009

A double-blinded and placebo-controlled clinical trial has begun at the Shalvata Mental Health Center to explore the efficacy and safety of Deep TMS in 50 subjects with bipolar depression, currently treated with mood stabilizers and previously unsuccessfully treated with antidepressant medication.


Autism - Double-Blind Placebo Control Safety and Feasibility Study

The Alfred Hospital and Monash University, Melbourne, Australia

12 February, 2008

Brainsway Ltd. (the "Company") is pleased to announce that on this day, February 12th 2008, it has entered into an agreement with the Alfred Psychiatry Research Centre in Melbourne, Australia (the "Alfred Centre") to perform human clinical trials.


Parkinson's Disease - Double-Blind Placebo Control Safety and Feasibility Study

Sheba Medical Center, Tel Hashomer , Israel

28 January, 2008

A clinical trial using Brainsway's Deep TMS device for the treatment of Parkinson’s disease has begun at the Sheba Medical Center at Tel Hashomer, Israel.

40 patients are expected to take part in the trial


Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 3rd floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.